Pandemic influenza vaccination coverage in children with type 1 diabetes: analysis from seven Italian centers

Hum Vaccin. 2011 Dec;7(12):1291-2. doi: 10.4161/hv.7.12.18335. Epub 2011 Dec 1.

Abstract

The pandemic influenza vaccination coverage in children with type 1 diabetes has been analysed. 1461 charts have been reviewed (788 M and 673 F, ages 13.0±4.1 yrs, disease duration 6.0±4.8 yrs, HbA1c 7.9±1.2%). Among them, 428 patients (29.3%) underwent A/H1N1 vaccination. A special effort is required to implement an increased immunization rate.

Publication types

  • Multicenter Study

MeSH terms

  • Adolescent
  • Child
  • Diabetes Mellitus, Type 1* / epidemiology
  • Diabetes Mellitus, Type 1* / immunology
  • Female
  • Hospitals, Pediatric
  • Humans
  • Influenza A Virus, H1N1 Subtype / immunology*
  • Influenza Vaccines / therapeutic use*
  • Influenza, Human / epidemiology
  • Influenza, Human / prevention & control*
  • Italy
  • Male
  • Pandemics
  • Vaccination / statistics & numerical data*

Substances

  • Influenza Vaccines